ArticleClinical rheumatology2026
Juvenile idiopathic arthritis-associated uveitis outcomes at an Australian tertiary paediatric hospital.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectivesWe performed a retrospective cohort study exploring juvenile idiopathic arthritis (JIA)-associated uveitis (JIA-U) screening practices and outcomes at a tertiary paediatric centre. The aim was to present data to inform a revised uveitis screening protocol.
methodAll patients diagnosed with JIA at the Royal Children's Hospital, Melbourne, Australia, between September 2021 and December 2023 were identified through the hospital electronic medical record. Demographic and clinical details were extracted and analysed.
resultsA total of 136 patients were identified and 107 were included in the analysis. Mean time from JIA diagnosis to chart review was 3.5 years. The mean age was 8.6 years and 71 (66.3%) were female. The most common JIA subtypes were oligoarticular (n = 41, 38.3%), rheumatoid factor negative polyarticular (n = 33, 30.8%) and enthesitis related (n = 15, 14.0%). Eighty-eight of 107 (82.2%) had at least one documented eye assessment overall including all 32 patients considered high-risk according to preexisting guidelines. Fifteen (14.0%) patients were diagnosed with uveitis; two prior to JIA diagnosis, seven within a year following JIA diagnosis and six more than a year following JIA diagnosis. At the time of uveitis diagnosis, three patients (20%) had ocular complications (two with synechiae, one with synechiae and vitreous haze) and none had significant visual loss.
conclusionsAdherence to preexisting JIA-U screening guidelines was suboptimal though better in high-risk patients. Few patients had significant ocular complications at time of uveitis diagnosis and none had significant visual impairment. Improved adherence to screening guidelines is an important step towards optimising uveitis outcomes.
Indexed as
Identifiers
42836944What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.